This study reported that knocking down the IGF1 gene in T2DM ADSCs might improve the transplantation efficiencies and revealed a new role of the IGF1 gene in stem cells, which has not been reported to date. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.